MedPath

Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ?

Phase 3
Completed
Conditions
Anal Incontinence
Interventions
Drug: CArbosylane
Registration Number
NCT01275560
Lead Sponsor
University Hospital, Rouen
Brief Summary

The objectives of this work are: 1/to estimate the frequency of a positive glucose breath test in favour of a small intestinal bacterial overgrowth in a population of patients consulting for gaz incontinence by comparison to a population of control subjects; 2/to estimate versus a conventional treatment the efficiency of an antibiotic treatment; in case of small intestinal bacterial overgrowth diagnosed by the glucose breath test, to improve gaz incontinence

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Gaz incontinence for more than 3 months
  • Afflilied to national health security
  • Having read and sign the information letter and consent form
Exclusion Criteria
  • Pregnancy
  • use of antibiotics, probiotics, IPP for less tha n 3 months
  • past of small intestinal bacterial overgrowth
  • ischemic, inflammatory colitis,colo-rectal cancer
  • diabetes
  • allergy to metronidazole
  • psychiatric disease
  • patients who do not speak or read french

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CarbosylaneCArbosylane3 intakes per daysduring 10 days
MetronidazoleMetronidazole3 intakes per day during 10 days
Primary Outcome Measures
NameTimeMethod
number of gaz incontinence episodes3 days before randomization and treatement and 3 days after 10 days of treatment (antibiotic or conventionnal treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Physiology Unit, Hopital Charles Nicolle, 1 rue de Germont

🇫🇷

Rouen, France

© Copyright 2025. All Rights Reserved by MedPath